Cargando…
The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease
BACKGROUND: Cholinergic dysfunction is a key abnormality in Alzheimer disease (AD) that can be detected in vivo with transcranial magnetic stimulation (TMS) protocols. Although TMS has clearly demonstrated analytical validity, its clinical utility is still debated. In the present study, we evaluated...
Autores principales: | Benussi, Alberto, Alberici, Antonella, Ferrari, Clarissa, Cantoni, Valentina, Dell’Era, Valentina, Turrone, Rosanna, Cotelli, Maria Sofia, Binetti, Giuliano, Paghera, Barbara, Koch, Giacomo, Padovani, Alessandro, Borroni, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145195/ https://www.ncbi.nlm.nih.gov/pubmed/30227895 http://dx.doi.org/10.1186/s13195-018-0423-6 |
Ejemplares similares
-
Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: impact on diagnostic confidence and diagnostic accuracy
por: Padovani, Alessandro, et al.
Publicado: (2019) -
Transcranial stimulation in frontotemporal dementia: A randomized, double‐blind, sham‐controlled trial
por: Benussi, Alberto, et al.
Publicado: (2020) -
Altered brain metabolic connectivity at multiscale level in early Parkinson’s disease
por: Sala, Arianna, et al.
Publicado: (2017) -
Home-based transcranial alternating current stimulation (tACS) in Alzheimer’s disease: rationale and study design
por: Altomare, Daniele, et al.
Publicado: (2023) -
Transcranial direct current stimulation enhances theory of mind in Parkinson’s disease patients with mild cognitive impairment: a randomized, double-blind, sham-controlled study
por: Adenzato, Mauro, et al.
Publicado: (2019)